Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...
Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...
Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 ...
Former European Trade Commissioner Phil Hogan and former US Senator Richard Burr, speaking on a panel at the J.P. Morgan ...
While Moderna’s full-year sales landed in the upper end of its target range, Jefferies analysts said further reductions are ...
FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback